Safety Data SheetChemical Risk Assessment

Abraxane Powder For Suspension For Infusion

by Celgene Corporation

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

Abraxane Powder For Suspension For Infusion is supplied by Celgene Corporation. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under OSHA regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 11 April 2018. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.


Language
English
Regulation
OSHA
Revision Date
11 Apr 2018
Signal Word
DANGER
Product Code
CAS Number

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.

Hazards at a GlanceFrom the Safety Data Sheet
Signal Word: DANGER

Health hazardGHS08Health hazard
Hazard Statements (H-phrases)
H341
Suspected of causing genetic defects.
H351
Suspected of causing cancer.
H360FD
See full Safety Data Sheet for the hazard statement wording.
H372
Causes damage to organs through prolonged or repeated exposure.

Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.


Common QuestionsAbout this Safety Data Sheet

Need help with Safety Data Sheets? You've come to the right place!

CONTACT US